ProtOS

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Celeris Therapeutics

The company develops artificial intelligence software to design and discover protein degrader drugs for pharmaceutical and biotechnology organisations.

DeepSeq.AI

DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.

DreamFold

This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

Proxima

Proxima develops artificial intelligence models and structural data platforms to design proximity-based medicines for pharmaceutical and biotechnology companies.

Prosemble

This biotechnology company develops an artificial intelligence and nanotechnology platform to design protein-based nanoparticle systems for precise drug delivery to cancer patients.

Diffuse Bio

This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.